Skip to main content
Premium Trial:

Request an Annual Quote

NYC Museum Licenses Biomatters Software

NEW YORK (GenomeWeb News) – The American Museum of Natural History in New York City has licensed data management software from Biomatters for use in its genomics sequencing programs, the company said today.

The museum will use the Geneious software for gene sequence visualization, assembly, primer design, and for BLAST searching at its Sackler Institute for Comparative Genomics.

The software will "support ongoing research investigating the tree of life, advancing the use of comparative genomics in biodiversity conservation, and developing innovative approaches to issues in human health and disease," SICG Manager Matthew Leslie said in a statement.

Under part of the agreement, Auckland, New Zealand-based Biomatters has agreed to donate several licenses to the Geneious software to Diponegoro University in Indonesia, the International Centre of Insect Physiology, and the University of the Philippines Marine Science Institute, the company said.

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.